Cargando…

COVID-19 Thrombosis: Understanding the Negative Predictive Value in a Pandemic

A test's negative predictive value-the probability that a negative result is a true negative result-is dependent on the prevalence of the condition. The present pandemic circumstances present us with unique challenges. False negatives in current testing methodology are to be expected.[1] Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almukhtar, Talat, Hajdenberg, Julio, Garcha, Gurjot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	331.Pathophysiology of Thrombosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330212/ http://dx.doi.org/10.1182/blood-2020-142127

Ejemplares similares

Thrombosis and Mortality in Pregnant Patients with COVID-19
por: Behrens, Elizabeth, et al.
Publicado: (2020)

Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients
por: Warrior, Surbhi, et al.
Publicado: (2020)

Low Rate of Thrombosis in Mexican Patients with COVID-19 Infection. a Benefit of Higher Doses Anticoagulants or a Sub Diagnosis?
por: Marquez, Félix Gibrant, et al.
Publicado: (2020)

Hematology Consultations during the COVID-19 Pandemic at a University Medical Center
por: Choi, Daniel C, et al.
Publicado: (2020)

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19
por: Gerotziafas, Grigoris, et al.
Publicado: (2020)

Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 Thrombosis
por: Madeeva, Daria V, et al.
Publicado: (2021)

Thrombocytopenia with and without Thrombosis Following COVID-19 Vaccination
por: Ge, Melissa, et al.
Publicado: (2021)

Deep Vein Thrombosis after COVID-19 Vaccinations
por: Houghton, Damon E., et al.
Publicado: (2021)

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study
por: Van Dreden, Patrick, et al.
Publicado: (2020)

Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Extensive Characterization of the Hemostatic Derangement Occurring in COVID-19 Patients Admitted to the Bergamo Hospital
por: Gomez-Rosas, Patricia, et al.
Publicado: (2020)

Thromboembolic Outcomes of Hospitalized COVID-19 Patients in the 90-Day Post-Discharge Period: Early Data from the Northwell CORE-19 Registry
por: Giannis, Dimitrios, et al.
Publicado: (2020)

Thrombotic Events in COVID-19 Patients and Its Comparison with Other Non-Sars-Cov-2 Respiratory Viruses
por: Tan, Jing Yuan, et al.
Publicado: (2020)

Association between ROTEM Hypercoagulable Profile and Outcome in a Cohort of Severely Ill COVID-19 Patients Under Mechanical Ventilation
por: Ratano, Damian, et al.
Publicado: (2020)

Prevalence of Low Limb Venous Thromboembolic Events in Mild and Severe/Critically Ill Patients with COVID-19 Despite Pharmacological Thromboprophylaxis
por: Zhang, Cong, et al.
Publicado: (2020)

Clinical Trial to Evaluate an Approved ITP Therapy Targeting Spleen Tyrosine Kinase (SYK) for Prevention and Treatment of COVID-19 Related Complications
por: Dummer, Wolfgang, et al.
Publicado: (2020)

Does Fibrin Structure Contribute to the Increased Risk of Thrombosis in COVID-19 ICU Patients?
por: De Vries, Judith Juliana, et al.
Publicado: (2021)

The Correlation between Racial/Ethnic Groups, Thrombosis, and Mortality in Hospitalized Patients with COVID-19
por: Rodriguez, Maya, et al.
Publicado: (2021)

Children and Young Adults Admitted to a NYC Children's Hospital Had a Similar Rate of Severe COVID-19 Coagulopathy As That Reported in Older Adults
por: Mitchell, William Beau, et al.
Publicado: (2020)

Biomarkers for Thrombosis in COVID-19: A Role for High Sensitivity Troponin-I and Immature Platelet Fraction?
por: Ashraf, Bilal, et al.
Publicado: (2021)

Inflammation Drives Coagulopathies in Sars-Cov-2 Patients
por: Sim, Martha MS, et al.
Publicado: (2020)

The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Post-Covid-19 Hemostatic Characteristics of Convalescent Patients: The Bergamo Experience
por: Tartari, Carmen Julia J, et al.
Publicado: (2021)

An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and Efficacy
por: Kaufman, Adrienne, et al.
Publicado: (2021)

The Impact of Degree of Anticoagulation on Thrombotic and Other Complications in Hospitalized COVID-19 Patients
por: Zheng, Rena, et al.
Publicado: (2021)

Comparison of Thrombotic Complications in Critically Ill Patients between COVID-19 and Mers-COV
por: Al Raizah, Abdulrahman, et al.
Publicado: (2021)

Thrombotic Events in COVID-19 Patients Undergoing Convalescent Plasma Therapy: A Systematic Review
por: Yu, Philip, et al.
Publicado: (2021)

COVID-19 Is Associated with Endothelial Dysfunction and Enhanced Plasma Thrombin Generation Despite Pharmacological Thromboprophylaxis
por: Kelliher, Sarah, et al.
Publicado: (2021)

A Rare Case of Mild COVID-19 Disease Associated with Type 1 Cryoglobulinemia and Thrombotic Thrombocytopenic Purpura
por: Naqvi, Syed Mujtaba, et al.
Publicado: (2021)

Inherited Thrombophilias Are Associated with an Increased Risk of COVID-19 Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study
por: Stevens, Hannah P, et al.
Publicado: (2021)

COVID-19 Diagnosis and Its Impact on Thrombotic Risk in a Cohort of Patients Simultaneously Hospitalized Due to Acute Respiratory Distress Syndrome
por: Coy-Canguçu, Andréa, et al.
Publicado: (2021)

Risk Stratification for Acute Arterial and Venous Thromboembolism using CHA (2)DS (2)-VASc Score in Hospitalized COVID-19 Patients: A Multicenter Study
por: Lee, Yi, et al.
Publicado: (2021)

Comparison of D-Dimer Level on Mild, Moderate and Severe COVID-19 at Immanuel Hospital Bandung City October 1 (st) - December 31 (st), 2020
por: Gustian, Hary, et al.
Publicado: (2021)

Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Monoclonal and Oligoclonal Anti-PF4 Antibodies Mediate VITT
por: Singh, Bandana, et al.
Publicado: (2021)

Vaccine-Induced Thrombotic Thrombocytopenia: Novelty Testing in the Diagnostic Work-up?
por: Cacciola, Rossella Rosari, et al.
Publicado: (2021)

Immunosuppressive Treatment Does Not Prevent Humoral and Cellular Virus-Specific Immunity in Heart or Lung Recipients with SARS-CoV-2 Pneumonia
por: Seminari, E., et al.
Publicado: (2021)

Predicting the risk of recurrent venous thrombosis: What the future might bring
por: Lijfering, Willem M., et al.
Publicado: (2019)

Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
por: Timp, Jasmijn F., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_827dumk7qd99nm7mmg26jkber9